MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could harm access to medicines for millions of people
Photo Credit: Lana Abramova
India has the highest burden of drug-resistant TB in the world with close to 1,00,000 suspected cases. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are on the rise, and access to new antibiotics will play a key role in developing new TB regimens to address growing treatment needs and improve cure rates.
Geneva, 21 March 2016—Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Doctors Without Borders / Médecins Sans Frontières (MSF).